Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango? | Front Immunol | 2022 | 36389779 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| Current landscape and future directions of bispecific antibodies in cancer immunotherapy. | Front Immunol | 2022 | 36389699 | PubTator, text mining | PubMed |
| The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma. | Comput Math Methods Med | 2022 | 36388161 | PubTator, text mining | PubMed |
| Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer. | Transl Cancer Res | 2022 | 36388031 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in cervical cancer: Current status and research progress. | Front Oncol | 2022 | 36387196 | PubTator, text mining | PubMed |
| Immune marker expression of irradiated mesothelioma cell lines. | Front Oncol | 2022 | 36387076 | PubTator, text mining | PubMed |
Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial. | BMJ Open | 2022 | 36375974 | PubTator, text mining | PubMed |
| Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma. | Cells | 2022 | 36359828 | PubTator, text mining | PubMed |
| The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer. | Biomedicines | 2022 | 36359346 | PubTator, text mining | PubMed |
| Impaired Heat Shock Protein Expression in Activated T Cells in B-Cell Lymphoma. | Biomedicines | 2022 | 36359267 | PubTator, text mining | PubMed |
| Tears as a Source of Biomarkers in the Diagnosis of Graves' Orbitopathy. | Biomolecules | 2022 | 36358969 | PubTator, text mining | PubMed |
| Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36358823 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors Related to Cardiotoxicity. | J Cardiovasc Dev Dis | 2022 | 36354777 | PubTator, text mining | PubMed |
| Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. | Front Genet | 2022 | 36353118 | PubTator, text mining | PubMed |
| Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. | Sci Transl Med | 2022 | 36350984 | PubTator, text mining | PubMed |
| Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival. | Front Immunol | 2022 | 36341460 | PubTator, text mining | PubMed |
| Impaired intratumoral natural killer cell function in head and neck carcinoma. | Front Immunol | 2022 | 36341402 | PubTator, text mining | PubMed |
| PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy. | Front Immunol | 2022 | 36341331 | PubTator, text mining | PubMed |
| Localization and movement of Tregs in gastrointestinal tract: a systematic review. | Inflamm Regen | 2022 | 36329556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=44